So far, more than 500 organisations (including universities, research institutes and private companies) and more than 1500 individuals from all over Europe and beyond have endorsed the Manifesto for EU COVID-19 research initiated by the European Commission. This shows a clear commitment and strong citizen engagement towards a better valorisation of research results.
The Commission has launched the manifesto to maximise the accessibility of research results in the fight against COVID-19. The manifesto provides guiding principles for beneficiaries of EU research grants for coronavirus prevention, testing, treatment and vaccination to ensure that their research results will be accessible for all and guarantee a return on public investment.
By endorsing the manifesto you commit to
- making the generated results, whether tangible or intangible, public and accessible without delay, for instance on the Horizon Results Platform, on an existing IP sharing platform, or through an existing patent pool
- making scientific papers and research data available in open access without delay and following the FAIR principles via preprint servers or public repositories, with rights for others to build upon the publications and data and with access to the tools needed for their validation.In particular, make COVID-19 research data available through the European COVID-19 Data Platform.
- where possible, granting for a limited time, non-exclusive royalty free licences on the intellectual property resulting from EU-funded research. These non-exclusive royalty free licenses shall be given in exchange for the licensees’ commitment to rapidly and broadly distribute the resulting products and services under fair and reasonable conditions to prevent, diagnose, treat and contain COVID-19.